EMA Rejects Bevacizumab Drug For Use In Wet AMD

European Commission Approves COVID-19 Products Ronapreve & Regkirona

 
• By Ian Schofield

Nearly a year and a half after it was filed for approval, the EU regulator has rejected a mystery injectable product containing the monoclonal antibody bevacizumab for ophthalmic use.

Macular degeneration - loss of the central field of vision.
Macular degeneration can seriously impair vision • Source: Alamy

More from Europe

More from Geography